95 related articles for article (PubMed ID: 21737503)
1. XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.
Vaezi A; Wang X; Buch S; Gooding W; Wang L; Seethala RR; Weaver DT; D'Andrea AD; Argiris A; Romkes M; Niedernhofer LJ; Grandis JR
Clin Cancer Res; 2011 Aug; 17(16):5513-22. PubMed ID: 21737503
[TBL] [Abstract][Full Text] [Related]
2. DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients.
Butkiewicz D; Krześniak M; Gdowicz-Kłosok A; Składowski K; Rutkowski T
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894339
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
[TBL] [Abstract][Full Text] [Related]
4. Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study.
Macedo LT; Costa EFD; Carvalho BF; Lourenço GJ; Calonga L; Castilho AM; Chone CT; Lima CSP
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980643
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
Noriega-Rivera R; Rivera-Serrano M; Rabelo-Fernandez RJ; Pérez-Santiago J; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887085
[TBL] [Abstract][Full Text] [Related]
6. THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients.
Yao Z; Lin A; Yi Y; Shen W; Zhang J; Luo P
Drug Des Devel Ther; 2022; 16():1679-1695. PubMed ID: 35685767
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas.
Griso AB; Acero-Riaguas L; Castelo B; Cebrián-Carretero JL; Sastre-Perona A
Cells; 2022 Feb; 11(3):. PubMed ID: 35159370
[TBL] [Abstract][Full Text] [Related]
8. Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy.
Marcu LG; Marcu DC
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834445
[TBL] [Abstract][Full Text] [Related]
9. DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients.
Bold IT; Specht AK; Droste CF; Zielinski A; Meyer F; Clauditz TS; Münscher A; Werner S; Rothkamm K; Petersen C; Borgmann K
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801877
[TBL] [Abstract][Full Text] [Related]
10. XPF expression and its relationship with the risk and prognosis of colorectal cancer.
Hu H; Jing J; Lu X; Yuan Y; Xing C
Cancer Cell Int; 2021 Jan; 21(1):12. PubMed ID: 33407486
[TBL] [Abstract][Full Text] [Related]
11. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.
Chen SH; Chang JY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450627
[TBL] [Abstract][Full Text] [Related]
12. Correlation of xeroderma pigmentosum complementation group F expression with gastric cancer and prognosis.
Li P; Ma Y
Oncol Lett; 2018 Dec; 16(6):6971-6976. PubMed ID: 30546430
[TBL] [Abstract][Full Text] [Related]
13. ERCC1, XPF and XPA-locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma.
Prochnow S; Wilczak W; Bosch V; Clauditz TS; Muenscher A
Clin Oral Investig; 2019 Aug; 23(8):3319-3329. PubMed ID: 30498981
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer.
Luo SS; Liao XW; Zhu XD
Biomed Res Int; 2018; 2018():6204684. PubMed ID: 30417012
[TBL] [Abstract][Full Text] [Related]
15. Association between common polymorphisms in
Li C; Yu X; Guo D; Liu G; Zhang K; Teng Q; Lin H
Onco Targets Ther; 2018; 11():3495-3504. PubMed ID: 29950854
[TBL] [Abstract][Full Text] [Related]
16. Association of XPF Levels and Genetic Polymorphism with Susceptibility to Ischemic Stroke.
Ma Y; Deng XD; Feng Y; Zhang W; Wang SX; Liu Y; Liu H
J Mol Neurosci; 2016 May; 59(1):168-76. PubMed ID: 26888738
[TBL] [Abstract][Full Text] [Related]
17. Expression of XPG protein in the development, progression and prognosis of gastric cancer.
Deng N; Liu JW; Sun LP; Xu Q; Duan ZP; Dong NN; Yuan Y
PLoS One; 2014; 9(9):e108704. PubMed ID: 25268735
[TBL] [Abstract][Full Text] [Related]
18. DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Seiwert TY; Wang X; Heitmann J; Villegas-Bergazzi V; Sprott K; Finn S; O'Regan E; Farrow AD; Weichselbaum RR; Lingen MW; Cohen EE; Stenson K; Weaver DT; Vokes EE
PLoS One; 2014; 9(7):e102112. PubMed ID: 25019640
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]